0O1O.LSE Vetoquinol

Healthcare Commercial Services & Supplies London Exchange
79.91 EUR
Close of Nov 3, 2026
66.30 89.98
Market cap
EUR 947M
P/E
15.8x
P/B
-
ROE
20.0%
Dividend yield
1.19%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is 0O1O.LSE undervalued?

Graham number

The Graham number of Vetoquinol cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Vetoquinol fundamental analysis

No fundamental analysis for Vetoquinol yet.

Vetoquinol stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Vetoquinol

Vetoquinol SA, a veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal medicine; and cardio-nephrology. The company was founded in …

Full company profile